These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33628015)

  • 1. Preference for Easyhaler
    Alvarez-Gutiérrez FJ; Gómez-Bastero Fernández A; Medina Gallardo JF; Campo Sien C; Rytilä P; Delgado Romero J
    Patient Prefer Adherence; 2021; 15():349-358. PubMed ID: 33628015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Asthma patient satisfaction with different dry powder inhalers.
    Valero A; Ribó P; Maíz L; Barbero E; Calle M; Campo C; Rytilä P; Giner J; Plaza V
    Expert Rev Respir Med; 2019 Feb; 13(2):133-138. PubMed ID: 30625015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usage and usability of one dry powder inhaler compared to other inhalers at therapy start: an open, non-interventional observational study in Poland and Germany.
    Hantulik P; Wittig K; Henschel Y; Ochse J; Vahteristo M; Rytila P
    Pneumonol Alergol Pol; 2015; 83(5):365-77. PubMed ID: 26378998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of satisfaction with different dry powder inhalation devices in Greek patients with COPD and asthma: the ANASA study.
    Zervas E; Samitas K; Gaga M
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1845-55. PubMed ID: 27540287
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of inhaler handling-errors, inhaler perception and preference with Spiromax, Easyhaler and Turbuhaler devices among healthy Finnish volunteers: a single site, single visit crossover study (Finhaler).
    Sandler N; Holländer J; Långström D; Santtila P; Saukkonen A; Torvinen S
    BMJ Open Respir Res; 2016; 3(1):e000119. PubMed ID: 27026804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of dry powder inhalers with a focus on ease of use and user preference in inhaler-naïve individuals.
    von Schantz S; Katajavuori N; Antikainen O; Juppo A
    Int J Pharm; 2016 Jul; 509(1-2):50-58. PubMed ID: 27208655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of real-life data on the use of inhaler devices, including satisfaction and adherence to treatment, by community pharmacists in partnership with pulmonary disease specialists.
    Gemicioglu B; Gungordu N; Can G; Alp Yıldırım FI; Uydeş Doğan BS
    J Asthma; 2023 Jul; 60(7):1326-1335. PubMed ID: 36332164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD.
    Gálffy G; Mezei G; Németh G; Tamási L; Müller V; Selroos O; Orosz M
    Drugs R D; 2013 Sep; 13(3):215-22. PubMed ID: 24043456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching to the Dry-Powder Inhaler Easyhaler
    Lavorini F; Chudek J; Gálffy G; Pallarés-Sanmartin A; Pelkonen AS; Rytilä P; Syk J; Szilasi M; Tamási L; Xanthopoulos A; Haahtela T
    Pulm Ther; 2021 Dec; 7(2):409-427. PubMed ID: 34581994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients.
    Voshaar T; Spinola M; Linnane P; Campanini A; Lock D; Lafratta A; Scuri M; Ronca B; Melani AS
    J Aerosol Med Pulm Drug Deliv; 2014 Oct; 27(5):363-70. PubMed ID: 24299501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of correct technique and preference for Spiromax®, Easyhaler® and Turbuhaler®: a single-site, single-visit, crossover study in inhaler-naïve adult volunteers.
    Rönmark P; Jagorstrand B; Safioti G; Menon S; Bjermer L
    Eur Clin Respir J; 2018; 5(1):1529536. PubMed ID: 30370020
    [No Abstract]   [Full Text] [Related]  

  • 12. Easyhaler
    Lavorini F
    Drugs Context; 2019; 8():212596. PubMed ID: 31210773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dry powder inhaler features of the Easyhaler that benefit the management of patients.
    Chrystyn H; Lavorini F
    Expert Rev Respir Med; 2020 Apr; 14(4):345-351. PubMed ID: 32013627
    [No Abstract]   [Full Text] [Related]  

  • 14. Effectiveness and Patient Satisfaction with Budesonide/Formoterol Easyhaler
    Gálffy G; Szilasi M; Tamási L
    Pulm Ther; 2019 Dec; 5(2):165-177. PubMed ID: 32026408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multicenter, Observational, Prospective Study of the Effectiveness of Switching from Budesonide/Formoterol Turbuhaler
    Syk J; Vinge I; Sörberg M; Vahteristo M; Rytilä P
    Adv Ther; 2019 Jul; 36(7):1756-1769. PubMed ID: 30941722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ease-of-use preference for the ELLIPTA® dry powder inhaler over a commonly used single-dose capsule dry powder inhaler by inhalation device-naïve Japanese volunteers aged 40 years or older.
    Komase Y; Asako A; Kobayashi A; Sharma R
    Int J Chron Obstruct Pulmon Dis; 2014; 9():1365-75. PubMed ID: 25525354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment of patient satisfaction and preferences with inhalers in asthma with the FSI-10 Questionnaire].
    Perpiñá Tordera M; Viejo JL; Sanchis J; Badia X; Cobos N; Picado C; Sobradillo V; Martínez González del Río J; Duce F; Muñoz Cabrera L
    Arch Bronconeumol; 2008 Jul; 44(7):346-52. PubMed ID: 18727886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD.
    Svedsater H; Dale P; Garrill K; Walker R; Woepse MW
    BMC Pulm Med; 2013 Dec; 13():72. PubMed ID: 24314123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A non-interventional switch study in adult patients with asthma or COPD on clinical effectiveness of salmeterol/fluticasone Easyhaler
    Vinge I; Syk J; Xanthopoulos A; Laßmann H; Vahteristo M; Sairanen U; Lähelmä S; Hennig R; Müller M
    Ther Adv Respir Dis; 2021; 15():17534666211027787. PubMed ID: 34344257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cradle-to-Grave Emission Reduction for Easyhaler Dry Powder Inhaler Product Portfolio.
    Inget M; Hisinger-Mölkänen H; Howard M; Lähelmä S; Paronen N
    Pulm Ther; 2023 Dec; 9(4):527-533. PubMed ID: 37749379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.